Foghorn Therapeutics Announces Upcoming Investor Conference Participation
Get Alerts FHTX Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced management's participation in the following investor conferences. With an initial focus in oncology, Foghorn’s Gene Traffic Control® Platform and resulting broad pipeline has the potential to transform the lives of people suffering from a wide spectrum of diseases.
Cowen's 3rd Annual Oncology Innovation Summit: Insights for ASCO & EHA
Thursday, June 2nd, 10:30 a.m. ET
Please find a link to the fireside chat here.
Jefferies Healthcare Conference
Wednesday, June 8th, 1:30 p.m. ET
Please find a link to the fireside chat here.
Goldman Sachs 43rd Annual Global Healthcare Conference
Monday, June 13th, 3:20 p.m. PT
Please find a link to the fireside chat here.
A webcast of the panel can also be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com and will be available for up to 90 days.
About Foghorn Therapeutics
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology with two currently being investigated in clinical studies.
Contact:
Ben Strain, Foghorn Therapeutics Inc. (Media and Investors)
[email protected]
Michael Lampe, ScientPR (Media)
[email protected]
Hans Vitzthum, LifeSci Advisors (Investors)
[email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stabilization Notice
- OKX Continues to Lead in Trust and Transparency with 18th Consecutive Proof of Reserves, Amounting to USD22.3 Billion
- NETA Auto: The First Car from the Indonesian Factory Powers up Global Strategy
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Goldman Sachs, Jefferies & Co, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!